SEC Company Response from Oncocyte Corp (OCX) (CIK 0001642380) (IMDX) — Dec 28, 2015
Oncocyte Corp (OCX) (CIK 0001642380)
Date: Dec. 28, 2015 · CIK: 0001642380 · Accession: 0001140361-15-045678
AI Filing Summary & Sentiment
File numbers found in text: 001-37648
Letter
1301 Harbor Bay Parkway
Alameda, CA 94502
T: 510-521-3390, F: 510-521-3389
www.oncocyte.com
December 28, 2015
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
RE: OncoCyte, Corporation
Form 10-12B
File No. 001-37648
Ladies/Gentlemen:
The undersigned registrant, OncoCyte, Corporation (the “Company”), hereby requests that its Registration Statement on Form 10, File No. 001-37648, be declared effective on Wednesday, December 30, 2015, or as soon thereafter as practicable.
The Company acknowledges that:
·
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
s/William Annett
Show Raw Text
CORRESP 1 filename1.htm 1301 Harbor Bay Parkway Alameda, CA 94502 T: 510-521-3390, F: 510-521-3389 www.oncocyte.com December 28, 2015 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 RE: OncoCyte, Corporation Form 10-12B File No. 001-37648 Ladies/Gentlemen: The undersigned registrant, OncoCyte, Corporation (the “Company”), hereby requests that its Registration Statement on Form 10, File No. 001-37648, be declared effective on Wednesday, December 30, 2015, or as soon thereafter as practicable. The Company acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, s/William Annett Chief Executive Officer